NIH-funded research R01 grant

Investigating how a specific receptor protects the brain after a stroke

Official title: Mechanistic inquiry of GPR68-mediated neuroprotection against post-stroke deficits and VCID

Funded at Tulane University of Louisiana · NIH-11247423 · Data updated 2026-11-12

This study is looking at how a special receptor called GPR68 can help keep brain cells safe during strokes, especially ischemic strokes, and aims to find new ways to prevent long-term problems after a stroke.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionTulane University of Louisiana
NIH-funded
Lab location1 site (New Orleans, United States)
Project startSeptember 25, 2023
Project endAugust 31, 2029
Funding year2023
Award (this year)$518,410
NIH project number7R01NS135594-02
Project IDNIH-11247423 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are individuals who have experienced an ischemic stroke and are at risk for post-stroke cognitive impairments.

Less likely to help

Patients who have not experienced a stroke or have other unrelated neurological conditions may not benefit from this research.

What this research studies

This research focuses on understanding how the GPR68 receptor can help protect brain cells from damage caused by strokes, particularly ischemic strokes. By studying both laboratory models and living organisms, the researchers aim to uncover the mechanisms through which GPR68 activates protective responses in neurons during and after a stroke. The goal is to identify new treatments that could prevent long-term cognitive impairments and disabilities that often follow a stroke.

Why it matters

Potential benefit: If successful, this research could lead to new therapies that significantly reduce the risk of cognitive decline and disabilities after a stroke.

How similar studies have gone: Previous research has shown promise in targeting similar neuroprotective mechanisms, suggesting that this approach could be effective.

Where this research is happening

  • Tulane University of Louisiana
    New Orleans, United States
    Active

Researchers

  • Principal investigator: Zha, Xiangming — Tulane University of Louisiana
  • Study coordinator: Zha, Xiangming

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.